ScinoPharm Taiwan Ltd (1789) — Net Asset Quality Index
ScinoPharm Taiwan Ltd (1789) has a Net Asset Quality Index of 88.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$11.86 Billion minus total liabilities of NT$1.33 Billion yields net assets of NT$10.52 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 1789 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
ScinoPharm Taiwan Ltd Net Asset Quality Index Over Time (2007–2025)
This chart shows how ScinoPharm Taiwan Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of December 2025, the index stands at 88.8%, representing net assets of NT$10.52 Billion against total assets of NT$11.86 Billion TWD. See ScinoPharm Taiwan Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for ScinoPharm Taiwan Ltd (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for ScinoPharm Taiwan Ltd from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of ScinoPharm Taiwan Ltd.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.8% | NT$10.52 Billion | NT$11.86 Billion | NT$1.33 Billion | ▲ +0.6 pp |
| 2024 | 88.1% | NT$10.53 Billion | NT$11.94 Billion | NT$1.42 Billion | ▼ -0.3 pp |
| 2023 | 88.4% | NT$10.36 Billion | NT$11.72 Billion | NT$1.36 Billion | ▲ +0.7 pp |
| 2022 | 87.7% | NT$10.45 Billion | NT$11.91 Billion | NT$1.46 Billion | ▼ -2.2 pp |
| 2021 | 89.9% | NT$10.51 Billion | NT$11.69 Billion | NT$1.18 Billion | ▲ +1.0 pp |
| 2020 | 88.9% | NT$10.53 Billion | NT$11.85 Billion | NT$1.32 Billion | ▲ +1.0 pp |
| 2019 | 87.9% | NT$10.26 Billion | NT$11.67 Billion | NT$1.41 Billion | ▲ +4.0 pp |
| 2018 | 83.9% | NT$10.54 Billion | NT$12.56 Billion | NT$2.02 Billion | ▲ +1.9 pp |
| 2017 | 82.0% | NT$10.42 Billion | NT$12.70 Billion | NT$2.28 Billion | ▲ +2.0 pp |
| 2016 | 80.0% | NT$10.23 Billion | NT$12.78 Billion | NT$2.56 Billion | ▼ -0.6 pp |
| 2015 | 80.7% | NT$9.86 Billion | NT$12.22 Billion | NT$2.36 Billion | ▼ -1.8 pp |
| 2014 | 82.5% | NT$9.38 Billion | NT$11.37 Billion | NT$1.99 Billion | ▼ -1.5 pp |
| 2013 | 84.0% | NT$9.64 Billion | NT$11.48 Billion | NT$1.84 Billion | ▼ -3.8 pp |
| 2012 | 87.7% | NT$9.07 Billion | NT$10.34 Billion | NT$1.27 Billion | ▼ -2.6 pp |
| 2011 | 90.3% | NT$8.56 Billion | NT$9.48 Billion | NT$920.78 Million | ▼ -1.2 pp |
| 2010 | 91.5% | NT$6.68 Billion | NT$7.30 Billion | NT$620.97 Million | ▲ +14.7 pp |
| 2009 | 76.8% | NT$4.47 Billion | NT$5.82 Billion | NT$1.35 Billion | ▲ +17.1 pp |
| 2008 | 59.7% | NT$3.44 Billion | NT$5.76 Billion | NT$2.32 Billion | ▲ +14.8 pp |
| 2007 | 44.9% | NT$2.53 Billion | NT$5.64 Billion | NT$3.10 Billion | — |